GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Enterprise Value

MKKGY (Merck KGaA) Enterprise Value : $72,182 Mil (As of Dec. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Merck KGaA's Enterprise Value is $72,182 Mil. Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was $4,006 Mil. Therefore, Merck KGaA's EV-to-EBIT ratio for today is 18.02.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Merck KGaA's Enterprise Value is $72,182 Mil. Merck KGaA's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $6,283 Mil. Therefore, Merck KGaA's EV-to-EBITDA ratio for today is 11.49.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Merck KGaA's Enterprise Value is $72,182 Mil. Merck KGaA's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $22,869 Mil. Therefore, Merck KGaA's EV-to-Revenue ratio for today is 3.16.


Merck KGaA Enterprise Value Historical Data

The historical data trend for Merck KGaA's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Enterprise Value Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65,523.42 88,063.31 123,678.88 93,226.73 78,060.07

Merck KGaA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81,513.11 78,060.07 84,790.49 80,698.68 85,349.52

Competitive Comparison of Merck KGaA's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Enterprise Value falls into.



Merck KGaA Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Merck KGaA's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Merck KGaA's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA  (OTCPK:MKKGY) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Merck KGaA's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=72182.214/4006.39
=18.02

Merck KGaA's current Enterprise Value is $72,182 Mil.
Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,006 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Merck KGaA's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=72182.214/6283.063
=11.49

Merck KGaA's current Enterprise Value is $72,182 Mil.
Merck KGaA's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,283 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Merck KGaA's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=72182.214/22868.795
=3.16

Merck KGaA's current Enterprise Value is $72,182 Mil.
Merck KGaA's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $22,869 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA Enterprise Value Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Q3 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Merck KGaA Capital Markets Day (Virtual) Transcript

By GuruFocus Research 02-14-2024

Merck KGaA's Dividend Analysis

By GuruFocus Research 04-29-2024

Q4 2022 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 05-16-2024

Q2 2023 Merck KGaA Earnings Press Conference Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024